All Updates

The Center for Medicare and Medicaid Services (CMS) issued guidance last night giving Medicare Advantage plans the option of applying step therapy for physician-administered and other Part B drugs, effective January 1, 2019.

LAKE NONA, Fla. —Aug. 7, 2018— More than 50 people attended today’s Florida Policy Forum on Clinical Trials hosted by the American Cancer Society Cancer Action Network (ACS CAN). The event brought together Florida research experts, government officials, patients and leaders from the cancer community to raise awareness about clinical

WASHINGTON, D.C. – Six leading public health and medical organizations today urged the U.S. Food and Drug Administration (FDA) to stop the sale of new electronic cigarette products that have been illegally introduced in recent months without the agency’s prior review and authorization. These include numerous products similar to the

Knoxville, TN — August 1, 2018 — Today, the University of Tennessee, Knoxville joined universities across the state in going smoke-free. The American Cancer Society Cancer Action Network (ACS CAN) commends the university for taking this important step to protect its staff, students and visitors from the dangers of secondhand

The Department of Health and Human Services (HHS), Department of Labor and Department of Treasury issued a final rule governing the extension of short-term limited-duration plans. Under the rule, insurers can issue new short-term plans that can be extended for up to 36 months.

Washington, D.C. – Senators Dick Durbin (D-Ill.) and Lisa Murkowski (R-Alaska) introduced legislation today that would prohibit the sale of most flavored tobacco products targeted to youth. While the Family Smoking Prevention and Tobacco Control Act of 2009 prohibited the use of flavors in cigarettes, except for menthol, flavors have

Washington, D.C. – August 1, 2018 – Today the U.S. Senate approved its FY 2019 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill. The bill preserves the Food and Drug Administration’s (FDA) authority over tobacco products and also boosts funding for FDA’s Oncology Center of Excellence